Mercator Medical S.A. (MRC.WA)
PLN 49.05
(-0.91%)
PLN 49.05
(-0.91%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 19.42 Million PLN | 82.14% |
| 2022 | -159.74 Million PLN | -108.73% |
| 2021 | 497.07 Million PLN | -48.17% |
| 2020 | 1.06 Billion PLN | 3767.12% |
| 2019 | 28.1 Million PLN | 1.49% |
| 2018 | 28.26 Million PLN | 57.36% |
| 2017 | 17.01 Million PLN | -34.26% |
| 2016 | 26.97 Million PLN | 42.97% |
| 2015 | 18.88 Million PLN | 15.05% |
| 2014 | 16.75 Million PLN | 16.37% |
| 2013 | 14.36 Million PLN | 19.9% |
| 2012 | 11.93 Million PLN | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -4.3 Million PLN | -123.72% |
| 2024 Q2 | 5.61 Million PLN | 265.55% |
| 2023 Q3 | -22.93 Million PLN | -324.44% |
| 2023 Q2 | 10.21 Million PLN | 297.93% |
| 2023 FY | - PLN | 82.14% |
| 2023 Q4 | -18.44 Million PLN | 19.56% |
| 2023 Q1 | -5.16 Million PLN | 92.3% |
| 2022 Q2 | 3.23 Million PLN | 144.25% |
| 2022 Q3 | 26.81 Million PLN | 727.88% |
| 2022 Q4 | -67.04 Million PLN | -350.01% |
| 2022 FY | - PLN | -108.73% |
| 2022 Q1 | -7.31 Million PLN | 75.66% |
| 2021 Q2 | 222.45 Million PLN | -26.62% |
| 2021 Q1 | 303.14 Million PLN | -23.36% |
| 2021 Q4 | -30.06 Million PLN | -152.05% |
| 2021 FY | - PLN | -48.17% |
| 2021 Q3 | 57.76 Million PLN | -74.03% |
| 2020 FY | - PLN | 3767.12% |
| 2020 Q2 | 235.58 Million PLN | 577.94% |
| 2020 Q3 | 400.98 Million PLN | 70.21% |
| 2020 Q4 | 395.54 Million PLN | -1.36% |
| 2020 Q1 | 34.75 Million PLN | 273.9% |
| 2019 Q3 | 7.21 Million PLN | -16.67% |
| 2019 FY | - PLN | 1.49% |
| 2019 Q2 | 8.65 Million PLN | 255.76% |
| 2019 Q4 | 9.29 Million PLN | 28.9% |
| 2019 Q1 | 2.43 Million PLN | -62.65% |
| 2018 Q2 | 4.3 Million PLN | -51.53% |
| 2018 FY | - PLN | 57.36% |
| 2018 Q3 | 7.48 Million PLN | 73.73% |
| 2018 Q4 | 6.51 Million PLN | -12.95% |
| 2018 Q1 | 8.88 Million PLN | 49.66% |
| 2017 FY | - PLN | -34.26% |
| 2017 Q1 | 4.32 Million PLN | -13.81% |
| 2017 Q2 | 2.83 Million PLN | -34.4% |
| 2017 Q3 | 4.17 Million PLN | 47.08% |
| 2017 Q4 | 5.93 Million PLN | 42.21% |
| 2016 Q2 | 6.34 Million PLN | -0.47% |
| 2016 Q3 | 8.54 Million PLN | 34.79% |
| 2016 Q4 | 5.01 Million PLN | -41.28% |
| 2016 Q1 | 6.37 Million PLN | 62.82% |
| 2016 FY | - PLN | 42.97% |
| 2015 Q3 | 4.66 Million PLN | 3.55% |
| 2015 FY | - PLN | 15.05% |
| 2015 Q2 | 4.5 Million PLN | -14.9% |
| 2015 Q1 | 5.29 Million PLN | 36.69% |
| 2015 Q4 | 3.91 Million PLN | -16.07% |
| 2014 Q4 | 3.87 Million PLN | -29.69% |
| 2014 FY | - PLN | 16.37% |
| 2014 Q1 | 2.67 Million PLN | -0.45% |
| 2014 Q2 | 3.92 Million PLN | 46.58% |
| 2014 Q3 | 5.5 Million PLN | 40.27% |
| 2013 Q2 | 3.34 Million PLN | -10.09% |
| 2013 Q4 | 2.68 Million PLN | -33.85% |
| 2013 FY | - PLN | 19.9% |
| 2013 Q1 | 3.71 Million PLN | 26.07% |
| 2013 Q3 | 4.06 Million PLN | 21.67% |
| 2012 FY | - PLN | 0.0% |
| 2012 Q3 | 2.94 Million PLN | 0.0% |
| 2012 Q4 | 2.94 Million PLN | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Airway Medix S.A. | -166 Thousand PLN | 11803.012% |